During the past decade, State Budget Medical Institution Sverdlovsk Regional Clinical Hospital N1 conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "State Budget Medical Institution Sverdlovsk Regional Clinical Hospital N1" are "Coronary Heart Disease (CHD)" (1 trials) and "Systemic Lupus Erythematosus (SLE)" (1 trials). Many other conditions were trialed in "State Budget Medical Institution Sverdlovsk Regional Clinical Hospital N1" in a lesser frequency.

Most popular intervention types in "State Budget Medical Institution Sverdlovsk Regional Clinical Hospital N1" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Evolocumab" (1 trials), "Placebo" (1 trials), "Placebo for Rozibafusp Alfa" (1 trials) and "Rozibafusp Alfa" (1 trials). Other intervention names were less common.

The vast majority of trials in "State Budget Medical Institution Sverdlovsk Regional Clinical Hospital N1" are 2 trials for "All" genders.

Currently, there are NaN active trials in "State Budget Medical Institution Sverdlovsk Regional Clinical Hospital N1". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in State Budget Medical Institution Sverdlovsk Regional Clinical Hospital N1, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in State Budget Medical Institution Sverdlovsk Regional Clinical Hospital N1, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".